fda approves generic glp 1 First GLP-1 Weight Loss Drug MedWatch Digest: FDA approves generic

10.1074/jbc.M103034200

Here are the most common worries, and how we address them: *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

Miyachi et al., 2004

Gas build up or wind is caused by a number of factors including: Inflammation and swelling with tissue injury (especially with abdominal hysterectomy) Constipation General anaesthetic Pain relieving medications Fasting for surgery Decreased walking and movement Slowed nervous system /neural changes Hormonal changes

Anticancer and chemosensitizing effects have also been reported in ovarian, cervical, and endometrial cancers